The study included tissue biopsies from 55 patients who had decompression or discectomy at Krembil Neuroscience Centre at Toronto Western Hospital. Researchers analyzed the “role, function and signaling mechanisms of two tissue biomarkers: microRNA-181a-5p and microRNA-4454,” according to Medical Xpress.
The Journal of Clinical Investigation Insight published the study.
Here are five observations:
1. The study revealed two tissue biomarkers that, when elevated, create inflammation, cartilage destruction and collagen depletion.
2. The researchers concluded measuring the levels of microRNA-181a-5p and microRNA-4454 may assist providers in pinpointing the state of disease progression.
3. These biomarkers also reveal the severity of cartilage destruction.
4. Further research involves determining whether the biomarkers are noticeable in blood.
5. The researchers hope their discovery will assist in developing a way to stop and reverse spine degeneration.
More articles on spine:
5 key notes on return-to-work rates after lumbar discectomy
8 things for spine surgeons to know for Thursday — August 4, 2016
Dr. Dante Leven joins Total Orthopedic and Sports Medicine: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
